Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CIR Panel Emphasizes GMPs In Final 'Safe As Used' Ingredient Reports

This article was originally published in The Rose Sheet

Executive Summary

Hexamethylene diisocyanate polymers and keratin/keratin-derived ingredients are safe as currently used in the cosmetics sector, provided that good manufacturing practices are being employed, the Cosmetic Ingredient Review Expert Panel suggests. The group issued four final assessments, advanced a slew of tentative reports and finalized its 2017 review priorities at its June 6-7 meeting in Washington.


Related Content

CIR Nearly Finished Assessing Citrus Component Safety
FDA Warning Letter Depicts Personal-Care Regulation's Present, Possible Future
ICCR Ushers Forth Updated Cosmetic GMP Guidelines From FDA





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts